{"id":734846,"date":"2021-04-15T14:55:00","date_gmt":"2021-04-15T14:55:00","guid":{"rendered":"https:\/\/www.pm360online.com\/?guid=4d1102ab01f0056f90b540b388a142a7"},"modified":"2021-04-15T14:55:00","modified_gmt":"2021-04-15T14:55:00","slug":"biosplice-therapeutics-closes-120-million-in-equity-financing-to-advance-its-alternative-splicing-platform-2","status":"publish","type":"post","link":"https:\/\/www.pm360online.com\/biosplice-therapeutics-closes-120-million-in-equity-financing-to-advance-its-alternative-splicing-platform-2\/","title":{"rendered":"Biosplice Therapeutics Closes $120 Million in Equity Financing to Advance Its Alternative Splicing Platform"},"content":{"rendered":"<p><![CDATA[SAN DIEGO, April  15, 2021  (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (\u201cBiosplice\u201d), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, announced today it has closed $120 million in equity financing from a new biotechnology investment syndicate. Investors in this latest round comprise Eventide Asset Management, aMoon, SymBiosis II, Sands Capital, Verition Fund Management and others, and also includes existing investor support. In conjunction with the financing, Joy Ghosh, PhD, of Eventide Asset Management and Gur Roshwalb, MD, of aMoon will be joining the company\u2019s Board of Directors.]]><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":74553,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[71350,71360],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/734846"}],"collection":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/users\/74553"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/comments?post=734846"}],"version-history":[{"count":0,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/734846\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/media?parent=734846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/categories?post=734846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/tags?post=734846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}